ClinicalTrials.govpublic full text
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
sarcoma, synovial, sarcoma,soft tissue, melanoma stage iv, triple negative breast cancer, metastatic cancer, non small cell lung cancer, bladder urothelial carcinoma, neuroblastoma, metastatic, ovary cancer, ny-eso-1, tcr, adoptive transfer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 801878
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.